Lusha vs ZoomInfo for Healthcare Data (2027)

In the Lusha vs ZoomInfo decision, Lusha fits individual reps and small teams that want fast contact lookups from LinkedIn or a company website, with published self-serve pricing. ZoomInfo fits larger revenue teams that need deeper company data, intent signals, and enterprise integrations, and can commit to an annual contract. For healthcare data, both are general B2B tools, so neither is built around NPI numbers, practice ownership, or hospital system affiliations.

This comparison covers data, features, pricing, and contracts, then looks at both through a healthcare lens: where each fits, where both fall short, and how to test them on your own target list.

Key takeaways

• Lusha is a lookup tool; ZoomInfo is a platform. Lusha is quick to adopt for one-off reveals. ZoomInfo adds company intelligence, intent, and workflow on top of contact data.
• Pricing models are opposite. Lusha publishes plans from a free tier upward; ZoomInfo quotes privately on annual contracts.
• Neither is healthcare-native. NPI matching, sub-specialty, practice ownership, and IDN or GPO affiliation are not core to either data model.
• Healthcare buyers are shifting to employed and system-owned models: only 42.2% of US physicians worked in private practice in 2024, down from 60.1% in 2012 (AMA).
• Decide with a test. Pull the same healthcare segment from each tool and compare match rate, bounce rate, and cost per qualified meeting.

Lusha vs ZoomInfo at a glance

Lusha vs ZoomInfo: Data Coverage and Accuracy

ZoomInfo has the larger and deeper database, especially for company-level data, org charts, and senior enterprise contacts. Lusha focuses on individual contact details, emails and phone numbers, that a rep can reveal in a click. Both publish database sizes and accuracy claims; neither is an independent audit.

How the data differs

What this means for healthcare data

Both tools organize people by company and title. Healthcare data needs a different structure:

• NPI-level identity. Every HIPAA-covered US provider has a 10-digit National Provider Identifier from the federal NPPES registry. Claims extracts, referral reports, and conference lists often arrive as NPI columns, and neither Lusha nor ZoomInfo is built to match on them.
• Practice ownership. In 2024, 34.5% of US physicians worked in hospital-owned practices, up from 23.4% in 2012 (AMA Physician Practice Benchmark Survey). Whether a physician owns the practice or is employed by a system changes who signs.
• System affiliation. About two-thirds of the 5,121 US community hospitals belong to a health system (AHA Fast Facts, 2026). Purchasing often runs through the parent IDN or a GPO contract, so hospital affiliation data matters before you build an account plan.
• Freshness. Ampliz’s internal tracking shows 1–2% of healthcare records go out of date every month. Ask both vendors how often each email and phone number is re-verified.

Data is half the decision; the other half is how your team uses it.

Lusha vs ZoomInfo: Features and workflow

Lusha is built around one quick action: reveal a contact’s email or phone number from a LinkedIn profile or company site, then push it to your CRM. ZoomInfo is built for teams that want account lists, signals, and enrichment flowing through their whole revenue stack.

Which workflow suits healthcare selling?

Lusha’s reveal-one-contact workflow works when you already know the person, such as a practice manager you found on LinkedIn. It is less helpful for building a list from scratch, like “every cardiology practice owner in Ohio,” because it has no healthcare-specific filters.

ZoomInfo’s account-first workflow suits health-system selling, where you map departments and decision makers across a large organization. It still lacks the healthcare structure that decides many deals: who owns the practice, which IDN a hospital belongs to, and which providers perform a given procedure.

Before comparing features, check whether either tool can answer questions like:

• “Which orthopedic practices in Texas are physician-owned?”
• “Who manages supply chain at hospitals in this IDN?”
• “Which of these 1,000 NPIs from our referral report can we reach by email?”

Our guide to healthcare sales strategy covers how these buying groups work in practice.

Then there’s cost, which is where the two differ most.

Lusha vs ZoomInfo: pricing and contracts

Lusha costs far less to start and publishes its prices. ZoomInfo does not publish pricing and sells annual contracts, so the real comparison depends on seats, credits, and modules.

Lusha pricing

Lusha’s published plans, as listed in late September 2026 with monthly billing, start at:

Annual billing lowers these prices, and Lusha often runs promotional rates, so check the live page before budgeting. Pro and Premium are sold on a credit slider, so the price rises with the credit volume you choose. A phone number reveal costs several credits, while an email costs one, so calling-heavy teams use credits much faster. Our Lusha pricing guide covers the plans in more detail.

ZoomInfo pricing

ZoomInfo quotes each deal privately based on seats, credits, and product modules. Procurement marketplace Vendr reports a median ZoomInfo contract of about $30,000 a year across purchases it tracks. Contracts are annual and commonly renew automatically unless you give notice. See our ZoomInfo pricing guide for the plan structure.

What the price gap means for healthcare teams

If healthcare is your only market, ZoomInfo means paying for a cross-industry license you won’t use, and Lusha means spending credits on reveals that may turn out to be the wrong role or a stale number. In both cases, the useful number is cost per qualified meeting with a healthcare buyer, not cost per seat or per credit.

So where does each one actually fit for healthcare data?

Lusha vs ZoomInfo for healthcare data

For healthcare data, the gap Lusha and ZoomInfo share matters more than their differences. Both work best when your healthcare buyer looks like any other corporate buyer. Both are weaker when the buyer is a physician, a practice owner, or a department inside a health system.

Where each one fits

• Lusha fits recruiters and small sales teams who already know the person they want, such as a practice manager found on LinkedIn, and need an email or direct dial quickly.
• ZoomInfo fits teams selling to health-system corporate roles (CFO, CIO, HR, procurement) at large organizations, especially healthtech or services companies that also sell into other industries.

Where both fall short

The healthcare-native option: Ampliz

If every buyer you target is in US healthcare, a healthcare data platform answers those questions directly. Ampliz gives you access to 6.8M+ healthcare providers and 11M+ healthcare executives. Records are drawn from sources such as the NPI Registry and CMS, emails are re-verified every 30 days, and credits are returned for any contact you flag as incorrect.

• HCP Lookup: filter providers by specialty, sub-specialty, practice ownership, practice size, and CPT/HCPCS procedure codes.
• Executive Search: find practice managers, supply chain directors, or CIOs by department, facility type, bed size, and EHR vendor.
• Hospital Analytics: see bed count, payer mix, parent IDN, and GPO relationships from the hospital database.
• NPI Lookup and Data Enrichment Engine: upload NPIs or names and get them back with verified email, phone, and LinkedIn.
• Compliance: HIPAA, CAN-SPAM, and GDPR (details).

The trade-off: Ampliz covers healthcare only, so teams that also sell into other industries may keep Lusha or ZoomInfo for those segments. For head-to-head detail, see Ampliz vs Lusha and Ampliz vs ZoomInfo.

Compare all three on your own segment. Book a demo and we’ll build a live list from your ICP, for example, “dermatology practice owners in Arizona,” so you can set it next to your Lusha or ZoomInfo export. Book a demo

Lusha or ZoomInfo: which should you choose?

Choose by who you sell to, how big your team is, and whether you build lists or look up individuals. The table gives a starting point.

How to test before you buy or renew

1. Write one narrow segment. Example: “practice administrators at independent orthopedic groups with 5–20 providers in Texas.”
2. Pull it from each tool and record records returned and fields filled (verified email, direct dial, NPI, ownership, affiliation).
3. Run an NPI match test on 500–1,000 NPIs from a list you already own.
4. Verify every export with the same email verifier and record bounce rates.
5. Send the same sequence to a sample from each list, with identical copy and timing.
6. Compare cost per qualified meeting, including credit usage for phone numbers and any contract minimums.

If you’re on a ZoomInfo contract, start 60–90 days before the renewal notice date. For wider shortlists, see our guides to Lusha alternatives, ZoomInfo alternatives, and Apollo vs ZoomInfo.

Common mistakes

• Judging by database size. A larger general database can still return fewer usable records for “pediatric gastroenterologists in the Bay Area” than a smaller healthcare-specific one.
• Underestimating phone-credit costs. On credit-based plans, phone reveals cost more than emails; model your real calling volume before picking a tier.
• Skipping verification. Sending unverified lists from your main domain risks your sender reputation. Our guide on why healthcare prospects ignore emails covers deliverability fixes.
• Ignoring compliance. CAN-SPAM makes no exception for business-to-business email: you need accurate sender details, a working opt-out honored within 10 business days, and a valid postal address.

FAQs

Is Lusha cheaper than ZoomInfo?

Yes, for most teams. Lusha publishes plans starting with a free tier and paid tiers from $49.90 a month on monthly billing, with lower annual rates. ZoomInfo does not publish pricing and sells annual contracts; Vendr’s marketplace data puts the median ZoomInfo contract at about $30,000 a year. Heavy phone-number use can raise Lusha’s real cost, so compare total spend.

Which has more accurate data, Lusha or ZoomInfo?

Third-party comparisons more often rate ZoomInfo higher on depth and accuracy, especially for enterprise contacts, and reviewers of both tools report outdated records. Both vendors publish their own accuracy claims, and neither is independently audited. Pull the same list from both and compare bounce rates before deciding.

Can Lusha replace ZoomInfo?

For reps who mainly use ZoomInfo to look up individual emails and phone numbers, often yes. For teams that rely on ZoomInfo’s company intelligence, intent data, website visitor tracking, or enterprise integrations, Lusha covers only part of that.

Is Lusha or ZoomInfo better for healthcare data?

ZoomInfo is usually stronger for corporate roles at large health systems; Lusha is quicker for one-off lookups when you already know the person. Neither is built around NPI numbers, practice ownership, or IDN and GPO affiliation. Teams that sell only into US healthcare usually get better targeting from a healthcare-native platform such as Ampliz.

Does Lusha or ZoomInfo have NPI data?

Neither is built around NPI-level provider records. If your lists arrive as NPIs from claims, referral, or conference data, use a healthcare data platform that matches on NPI. Ampliz’s free NPI Lookup is a quick way to check individual providers.

Is it legal to email healthcare contacts from these databases?

US commercial email is governed by CAN-SPAM, which makes no exception for business-to-business messages. You need accurate sender details, a working opt-out, and a valid postal address. This is general information, not legal advice; check with your counsel.

Conclusion: Lusha vs ZoomInfo for healthcare data

Lusha vs ZoomInfo comes down to how you work. Lusha suits reps and small teams who look up individual contacts and want published, low-entry pricing. ZoomInfo suits larger teams that build account lists at scale and use intent data and enterprise integrations. For healthcare data, both share the same gap: neither is organized around NPI numbers, practice ownership, or health system affiliation. If healthcare is your only market, test a healthcare-native platform alongside them, and judge all three by cost per qualified meeting on one real segment.

Ready to see your healthcare segment side by side? Book a demo and tell us who you sell to, such as “cardiology practice owners in Florida” or “supply chain directors at 100–300 bed hospitals in the Midwest.” We’ll build the list live in Ampliz, show you the filters behind it, and walk through how 30-day verification and credit-back on flagged contacts work. Book a demo

Subbu

V. SubramanyamHead of Product at Ampliz | Healthcare Data & GTM Intelligence Expert
V. Subramanyam is the Head of Product at Ampliz, where he leads the strategy and development of healthcare data intelligence solutions that help sales, marketing, recruiting, and commercial teams identify and engage healthcare decision-makers across the United States.
With extensive experience in product management, healthcare data, B2B SaaS, GTM strategy, and sales intelligence, he focuses on building products that simplify healthcare prospecting through accurate physician, hospital, executive, and healthcare organization data. His work emphasizes data quality, enrichment, and AI-powered workflows that enable organizations to make faster, data-driven decisions.
Connect with Him:

LinkedIn: https://www.linkedin.com/in/vsubramanyam
Company: https://www.ampliz.com